Clinical Trial Update: Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the early bactericidal activity, safety, and tolerability of nebulised RESP301 in adults with rifampicin-susceptible pulmonary tuberc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• RESP301

Snippet

Sponsor: Thirty Respiratory Limited | Conditions: Rifampicin Susceptible Pulmonary Tuberculosis | Phase 2 | Status: TERMINATED | Results posted: 2025-07-15